387 related articles for article (PubMed ID: 34525338)
21. Impact of Disease-Associated Mutations on the Deaminase Activity of ADAR1.
Karki A; Campbell KB; Mozumder S; Fisher AJ; Beal PA
Biochemistry; 2024 Feb; 63(3):282-293. PubMed ID: 38190734
[TBL] [Abstract][Full Text] [Related]
22. Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development.
Pestal K; Funk CC; Snyder JM; Price ND; Treuting PM; Stetson DB
Immunity; 2015 Nov; 43(5):933-44. PubMed ID: 26588779
[TBL] [Abstract][Full Text] [Related]
23. Effects of Aicardi-Goutières syndrome mutations predicted from ADAR-RNA structures.
Fisher AJ; Beal PA
RNA Biol; 2017 Feb; 14(2):164-170. PubMed ID: 27937139
[TBL] [Abstract][Full Text] [Related]
24. What do editors do? Understanding the physiological functions of A-to-I RNA editing by adenosine deaminase acting on RNAs.
Heraud-Farlow JE; Walkley CR
Open Biol; 2020 Jul; 10(7):200085. PubMed ID: 32603639
[TBL] [Abstract][Full Text] [Related]
25. An AGS-associated mutation in ADAR1 catalytic domain results in early-onset and MDA5-dependent encephalopathy with IFN pathway activation in the brain.
Guo X; Steinman RA; Sheng Y; Cao G; Wiley CA; Wang Q
J Neuroinflammation; 2022 Dec; 19(1):285. PubMed ID: 36457126
[TBL] [Abstract][Full Text] [Related]
26. The phenotype of the most common human ADAR1p150 Zα mutation P193A in mice is partially penetrant.
Liang Z; Chalk AM; Taylor S; Goradia A; Heraud-Farlow JE; Walkley CR
EMBO Rep; 2023 May; 24(5):e55835. PubMed ID: 36975179
[TBL] [Abstract][Full Text] [Related]
27. Differential Structural Features of Two Mutant ADAR1p150 Zα Domains Associated with Aicardi-Goutières Syndrome.
Langeberg CJ; Nichols PJ; Henen MA; Vicens Q; Vögeli B
J Mol Biol; 2023 Apr; 435(8):168040. PubMed ID: 36889460
[TBL] [Abstract][Full Text] [Related]
28. ADAR1 edits the SenZ and SenZ-ability of RNA.
Zillinger T; Bartok E
Immunity; 2021 Sep; 54(9):1909-1911. PubMed ID: 34525334
[TBL] [Abstract][Full Text] [Related]
29. Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis.
Heraud-Farlow JE; Chalk AM; Linder SE; Li Q; Taylor S; White JM; Pang L; Liddicoat BJ; Gupte A; Li JB; Walkley CR
Genome Biol; 2017 Sep; 18(1):166. PubMed ID: 28874170
[TBL] [Abstract][Full Text] [Related]
30. ADAR1, inosine and the immune sensing system: distinguishing self from non-self.
Liddicoat BJ; Chalk AM; Walkley CR
Wiley Interdiscip Rev RNA; 2016; 7(2):157-72. PubMed ID: 26692549
[TBL] [Abstract][Full Text] [Related]
31. Adenosine-to-inosine RNA editing in the immune system: friend or foe?
Nakahama T; Kawahara Y
Cell Mol Life Sci; 2020 Aug; 77(15):2931-2948. PubMed ID: 31996954
[TBL] [Abstract][Full Text] [Related]
32. RNA sensing via the RIG-I-like receptor LGP2 is essential for the induction of a type I IFN response in ADAR1 deficiency.
Stok JE; Oosenbrug T; Ter Haar LR; Gravekamp D; Bromley CP; Zelenay S; Reis e Sousa C; van der Veen AG
EMBO J; 2022 Mar; 41(6):e109760. PubMed ID: 35156720
[TBL] [Abstract][Full Text] [Related]
33. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.
Yang S; Deng P; Zhu Z; Zhu J; Wang G; Zhang L; Chen AF; Wang T; Sarkar SN; Billiar TR; Wang Q
J Immunol; 2014 Oct; 193(7):3436-45. PubMed ID: 25172485
[TBL] [Abstract][Full Text] [Related]
34. Bilateral striatal necrosis in two subjects with Aicardi-Goutières syndrome due to mutations in ADAR1 (AGS6).
La Piana R; Uggetti C; Olivieri I; Tonduti D; Balottin U; Fazzi E; Orcesi S
Am J Med Genet A; 2014 Mar; 164A(3):815-9. PubMed ID: 24376015
[TBL] [Abstract][Full Text] [Related]
35. ADAR1 Prevents Autoinflammatory Processes in the Heart Mediated by IRF7.
Garcia-Gonzalez C; Dieterich C; Maroli G; Wiesnet M; Wietelmann A; Li X; Yuan X; Graumann J; Stellos K; Kubin T; Schneider A; Braun T
Circ Res; 2022 Sep; 131(7):580-597. PubMed ID: 36000401
[TBL] [Abstract][Full Text] [Related]
36. LINE1 contributes to autoimmunity through both RIG-I- and MDA5-mediated RNA sensing pathways.
Zhao K; Du J; Peng Y; Li P; Wang S; Wang Y; Hou J; Kang J; Zheng W; Hua S; Yu XF
J Autoimmun; 2018 Jun; 90():105-115. PubMed ID: 29525183
[TBL] [Abstract][Full Text] [Related]
37. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
Liu Y; Wolff KC; Jacobs BL; Samuel CE
Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
[TBL] [Abstract][Full Text] [Related]
38. Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.
Livingston JH; Crow YJ
Neuropediatrics; 2016 Dec; 47(6):355-360. PubMed ID: 27643693
[TBL] [Abstract][Full Text] [Related]
39. RNA-Editing Enzyme ADAR1 p150 Isoform Is Critical for Germinal Center B Cell Response.
Li Y; Ruan GX; Chen W; Huang H; Zhang R; Wang J; Li Y; Xu S; Ou X
J Immunol; 2022 Sep; 209(6):1071-1082. PubMed ID: 35977796
[TBL] [Abstract][Full Text] [Related]
40. Z-DNA and Z-RNA in human disease.
Herbert A
Commun Biol; 2019; 2():7. PubMed ID: 30729177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
